| |
Overview
HeadlinesNo recent Headlines for this stock. Business Background Moleculin Biotech Inc is a clinical-stage pharmaceutical company. The company is engaged in the development of anti-cancer drug candidates. Its drug development technologies include liposomal Annamycin, WP1122 and WP1066.
| |